Capital Fund Management S.A. Bristol Myers Squibb CO Call Options Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $3.95 Million - $5.15 Million	99,500 Added 4.48%	2,322,200 $120 Million
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $6.58 Million - $8.66 Million	163,400 Added 7.93%	2,222,700 $92.3 Million
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $42.8 Million - $48.6 Million	-892,500 Reduced 30.24%	2,059,300 $112 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $60.1 Million - $71.8 Million	1,240,400 Added 72.48%	2,951,800 $151 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $26.5 Million - $29.7 Million	458,400 Added 36.58%	1,711,400 $99.3 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $38.9 Million - $43.2 Million	610,500 Added 95.02%	1,253,000 $80.1 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $5.53 Million - $6.28 Million	84,200 Added 15.08%	642,500 $44.5 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $8.25 Million - $9.77 Million	120,500 Added 27.52%	558,300 $40.2 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $1,586 - $937,448	-12,200 Reduced 2.71%	437,800 $31.1 Billion
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $13.5 Million - $14.9 Million	185,700 Added 70.26%	450,000 $34.7 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $3.27 Million - $3.92 Million	53,200 Added 25.2%	264,300 $19.3 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $1.05 Million - $1.22 Million	-19,500 Reduced 8.46%	211,100 $13.2 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $8.52 Million - $9.98 Million	144,000 Added 166.28%	230,600 $13.6 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $3.05 Million - $3.43 Million	51,400 Added 146.02%	86,600 $5.47 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $25.6 Million - $29.1 Million	-444,000 Reduced 92.65%	35,200 $2.18 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $9.01 Million - $9.99 Million	156,900 Added 48.68%	479,200 $28.9 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $38.2 Million - $44.6 Million	-696,500 Reduced 68.36%	322,300 $19 Million
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $21.8 Million - $31.7 Million	469,500 Added 85.47%	1,018,800 $56.8 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $21.1 Million - $27.6 Million	429,300 Added 357.75%	549,300 $35.3 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $1.14 Million - $1.35 Million	26,700 Added 28.62%	120,000 $6.09 Million
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $410,504 - $453,928	9,200 Added 10.94%	93,300 $4.23 Million
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $18.4 Million - $22 Million	-408,000 Reduced 82.91%	84,100 $4.01 Million
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $11.8 Million - $15.4 Million	-243,000 Reduced 33.06%	492,100 $25.6 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $43.8 Million - $49.4 Million	-793,100 Reduced 51.9%	735,100 $45.6 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $73.4 Million - $91.5 Million	1,452,500 Added 1918.76%	1,528,200 $84.6 Million
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $2.42 Million - $2.79 Million	-40,400 Reduced 34.8%	75,700 $4.79 Million
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $815,184 - $888,759	-13,600 Reduced 10.49%	116,100 $7.12 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $7.16 Million - $8.27 Million	129,700	129,700 $8.27 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.9 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.16 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.37 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.5 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.53 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account